From: Prognosis of patients with suspected pulmonary embolism in Buenos Aires: a prospective cohort study
Confirmed PE | Ruled out PE | p | |
---|---|---|---|
n = 504 | n = 1232 | ||
Median age (IQR, interquartile range) years | 71 (60–80) | 71 (58–81) | 0.36 |
Sex-Female, % (n) | 58% (291) | 60% (736) | 0.45 |
Median stay (IQR) days | 8 (5–15) | 8 (4–14) | 0.78 |
Comorbidities | |||
Diabetes | 12% (61) | 15% (187) | 0.09 |
Hypertension | 63% (313) | 67% (816) | 0.09 |
Smoking | 13% (64) | 12% (144) | 0.56 |
Heart Failure | 10% (50) | 20% (241)* | 0.001 |
Coronary heart disease | 10% (47) | 14% (166)* | 0.016 |
Dyslipidemia | 48% (242) | 45% (548) | 0.2 |
Cerebrovascular Accident | 5% (25) | 6% (75) | 0.47 |
Active neoplasia | 40% (201) | 40% (487) | 0.89 |
Liver disease | 1% (6) | 1% (1) | 0.50 |
Nephrotic syndrome | 2% (7) | 1% (4)* | 0.012 |
Charlson Score* | 2 (0–3) | 2 (1–4)* | 0.025 |
Immobilization within 4 weeks | 64% (304) | 64% (732) | 0.98 |
Median Body Mass Index (IQR) kg/m2 | 29 (25–31) | 28 (24–30)* | 0.05 |